Article

New York University/MEETH residency program highlighted

Joshua D. Stein, MD, MS, received his Bachelor of Arts degree from Wesleyan University with a double major in neuroscience and behavior and psychology. He then attended the Center for the Evaluative Clinical Sciences at Dartmouth Medical School and received a Master of Science degree. From there, he went on to Jefferson Medical College and obtained his Doctor of Medicine degree. Dr. Stein is currently a chief resident in ophthalmology in the New York University School of Medicine/Manhattan Eye, Ear and Throat Hospital (MEETH) residency program, and will pursue a fellowship in glaucoma at Duke University next year. Dr. Stein is a prolific researcher and investigator, having published numerous articles in peer-reviewed journals and presented his research at many national and international meetings.

The departments of ophthalmology at the New York University Medical Center and at MEETH both enjoy a long and storied history, producing some of the leading ophthalmologists of our time. In July 2000, a historic merger took place, combining the two programs into one. The program was expanded to seven residents per year, 21 in all, allowing our residents to experience the benefits of all of the hospitals we serve.

Our residents rotate through five different hospitals: the New York University Hospitals Center, MEETH, Bellevue Hospital, the Manhattan Veterans' Administration Medical Center, and Lenox Hill Hospital. Each hospital has a unique character and patient base, providing our residents with an extremely diverse and comprehensive experience in ophthalmology.

In July 2002, Dr. Jack Dodick became the acting chairman of the department of ophthalmology and a year later, the permanent chairman. Since that time, he has worked to unify and strengthen the residency program at the five hospitals, improving upon an already outstanding department.

In addition to rotating through the five hospitals, our residents enjoy an extensive didactic lecture series, taught by the ophthalmologists from all of our institutions. The Greater New York Ophthalmologic Clinical Lecture Series, attended by all of the ophthalmology residents in the New York area, is held at our institution, adding to the rich academic environment provided by our program.

This academic environment, combined with the diverse patient populations and attending ophthalmologists, as well as the resources of a major medical center, provides our residents with ample opportunity to conduct and become involved with research projects in the many subspecialties of ophthalmology. These research projects usually result in publications in the major ophthalmology journals as well as presentations at the major annual international ophthalmology meetings.

To help guide our residents through their training, we have instituted a mentoring program in which we assign each resident to two or three mentors, members of our faculty, usually in their primary area of interest, who provide support, advice, and guidance in research and in obtaining post-graduate fellowship training. This occurs at the end of the first year of residency or beginning of the second, and these mentors help guide the residents through their career choices.

At the beginning of the first year, each first year resident is assigned a third-year "buddy" to help them adjust to their new position.

Our residency program provides a unique training opportunity for resident applicants who wish to obtain medical and surgical ophthalmology training in a rich, diverse, exciting and challenging residency program.

-Laurence T.D. Sperber, MD, is a Residency Program Director Department of Ophthalmology New York University School of Medicine.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.